Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Raw Materials (2018 - 2024)

Historic Raw Materials for Kyntra Bio (KYNB) over the last 7 years, with Q3 2024 value amounting to $948000.0.

  • Kyntra Bio's Raw Materials fell 1959.29% to $948000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $948000.0, marking a year-over-year decrease of 1959.29%. This contributed to the annual value of $787000.0 for FY2023, which is 3658.34% down from last year.
  • Kyntra Bio's Raw Materials amounted to $948000.0 in Q3 2024, which was down 1959.29% from $1.0 million recorded in Q2 2024.
  • Over the past 5 years, Kyntra Bio's Raw Materials peaked at $3.3 million during Q1 2021, and registered a low of $327000.0 during Q2 2020.
  • In the last 5 years, Kyntra Bio's Raw Materials had a median value of $1.2 million in 2023 and averaged $1.2 million.
  • In the last 5 years, Kyntra Bio's Raw Materials plummeted by 5897.11% in 2020 and then skyrocketed by 62069.72% in 2021.
  • Quarter analysis of 5 years shows Kyntra Bio's Raw Materials stood at $2.3 million in 2020, then crashed by 40.82% to $1.4 million in 2021, then dropped by 8.95% to $1.2 million in 2022, then plummeted by 36.58% to $787000.0 in 2023, then grew by 20.46% to $948000.0 in 2024.
  • Its Raw Materials was $948000.0 in Q3 2024, compared to $1.0 million in Q2 2024 and $1.1 million in Q1 2024.